We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEAT
1701
DELISTED
BioTelemetry, Inc.
BEAT
| $1.53M | ﹤0.01% |
52,930
+15,986
| +43% | +$396K |
|
|
TLRD
1702
DELISTED
Tailored Brands, Inc.
TLRD
| $1.53M | ﹤0.01% |
102,266
+28,088
| +38% | +$565K |
|
|
AERI
1703
DELISTED
Aerie Pharmaceuticals
AERI
| $1.53M | ﹤0.01% |
33,676
+3,816
| +13% | +$170K |
|
1704
Universal Insurance Holdings
UVE
$1.22B
| $1.52M | ﹤0.01% |
62,215
+18,487
| +42% | +$484K |
|
1705
Forum Energy Technologies
FET
$708M
| $1.52M | ﹤0.01% |
3,677
+98
| +3% | +$42.1K |
|
|
RTEC
1706
DELISTED
Rudolph Technologies Inc
RTEC
| $1.52M | ﹤0.01% |
67,728
+17,285
| +34% | +$386K |
|
|
VG
1707
DELISTED
Vonage Holdings Corporation
VG
| $1.51M | ﹤0.01% |
239,690
+6,776
| +3% | +$45.1K |
|
|
CBB
1708
DELISTED
Cincinnati Bell Inc.
CBB
| $1.51M | ﹤0.01% |
85,551
+24,001
| +39% | +$498K |
|
|
KYNB
1709
Kyntra Bio
KYNB
$27.2M
| $1.51M | ﹤0.01% |
2,447
+175
| +8% | +$107K |
|
1710
Onto Innovation
ONTO
$12.9B
| $1.5M | ﹤0.01% |
49,395
+14,682
| +42% | +$398K |
|
|
PMT
1711
PennyMac Mortgage Investment
PMT
$822M
| $1.5M | ﹤0.01% |
84,764
+2,446
| +3% | +$41.5K |
|
1712
Cohen & Steers
CNS
$4.23B
| $1.5M | ﹤0.01% |
37,633
+845
| +2% | +$30.6K |
|
1713
First Bancorp
FBP
$4.42B
| $1.5M | ﹤0.01% |
265,836
+92,876
| +54% | +$590K |
|
|
RDUS
1714
DELISTED
Radius Health, Inc.
RDUS
| $1.5M | ﹤0.01% |
38,740
+1,512
| +4% | +$63.4K |
|
1715
Fossil Group
FOSL
$293M
| $1.49M | ﹤0.01% |
85,576
+662
| +0.8% | +$14K |
|
|
CYS
1716
DELISTED
CYS Investments Inc.
CYS
| $1.49M | ﹤0.01% |
187,835
+9,167
| +5% | +$71.8K |
|
|
TPC
1717
Tutor Perini Cor
TPC
$4.41B
| $1.49M | ﹤0.01% |
46,852
+1,352
| +3% | +$40.1K |
|
|
KND
1718
DELISTED
Kindred Healthcare
KND
| $1.49M | ﹤0.01% |
178,482
+45,996
| +35% | +$360K |
|
|
PEGI
1719
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $1.48M | ﹤0.01% |
73,708
+2,842
| +4% | +$56.8K |
|
|
STAY
1720
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $1.48M | ﹤0.01% |
92,928
+25,243
| +37% | +$419K |
|
|
HMHC
1721
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.48M | ﹤0.01% |
145,688
+7,507
| +5% | +$78.5K |
|
|
CALD
1722
DELISTED
Callidus Software, Inc.
CALD
| $1.47M | ﹤0.01% |
69,031
+3,019
| +5% | +$58K |
|
|
AY
1723
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $1.47M | ﹤0.01% |
70,249
+2,525
| +4% | +$53.2K |
|
|
GTY
1724
Getty Realty Corp
GTY
$2.11B
| $1.47M | ﹤0.01% |
58,229
+16,749
| +40% | +$431K |
|
1725
Alamo Group
ALG
$1.94B
| $1.47M | ﹤0.01% |
19,300
+5,325
| +38% | +$407K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.